Arylamine N-acetyltransferase as a potential biomarker in bladder cancer: Fluorescent in situ hybridization and immunohistochemistry studies

Biomarkers

Volumn 1, Issue 1, 1996, Pages 55-61

  Stacey, Michael ^a   Thygesen, Peter ^a   Stanley, Lesley ^a   Matas, Nada ^a   Risch, Angela ^a   Sim, Edith ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Arylamine N acetyltransferase; Bladder epithelial cells; Chromosome 8; Fluorescent in situ hybridization

Indexed keywords

EID: 0003089773     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.3109/13547509609079347     Document Type: Article

References (48)

1. ANAND, R., RILEY, J. H., SMITH, J. C. AND MARKHAM, A. F. (1990) A 3.5 genome equivalent multi-access YAC library: construction, characterisation, screening and storage. Nucleic Acid Research, 18, 1951-1956.
2. BELL, D. A., STEPHENS, E. A., CASTRIANO, T., UMBACH, D. M., WATSON, M., DEAKIN, M., ELDER, J., HENRICKSE, C., DUNCAN, H. AND STRANGE, R. C. (1995) Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Research, 55, 3537-3542.
3. BLUM, M., DEMIERRE, A., GRANT, D. M., HEIM, M. AND MEYER, U. A. (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proceedings of the National Academy of Sciences of the USA, 88, 5237-5241.
4. BROWN, T. A. (1991) Molecular Biology: Labfax (Bios Scientific, Oxford), p. 284.
5. BUCKLE, V. J. AND RACK, K. A. (1993) Fluorescence in situ hybridisation. In Human Genetic Disease Analysis: A Practical Approach, 2nd edition, K. E. Davies, ed. (Oxford University Press, Oxford), pp. 59-82.
6. BURKE, D. T., CARLE, G. F. AND OLSON, M. V. (1987) Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science, 236, 805-812.
7. CARTWRIGHT, R. A., GLASHAN, R. W., ROGERS, H. J., AHMAD, R. A., BARHAM-HALL, D., HIGGINS, E. AND KAHN, M. A. (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet, 2, 842-846.
8. CORONEOS, E. AND SIM, E. (1993) Arylamine N-acetyltransferase activity in human cultured cell lines. Biochemical Journal, 294, 481-486.
9. CORONEOS, E., GORDON, J. W., KELLY, S. L., WANG, P. D. AND SIM, E. (1991) Drug metabolising N-acetyltransferase activity in human cell lines. Biochimica et Biophysica Acta, 1073, 593-599.
10. CRIBB, A. E., GRANT, D. M., MILLER, M. A. AND SPIELBERG, S. P. (1991) Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leucocytes. Journal of Pharmacology and Experimental Therapeutics, 259, 1241-1246.
11. CRIBB, A. E., NAKAMURA, H., GRANT, D. M., MILLER, M. A. AND SPIELBERG, S. P. (1993) Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulphamethoxazole metabolism. Biochemical Pharmacology, 45, 1277-1282.
12. DEGUCHI, T. (1992) Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. Journal of Biological Chemistry, 267, 18140-18147.
13. FRANKE, S., KLAWITZ, I., SCHNAKENBERG, E., ROMMEL, B., VAN DE VEN, W., BULLERDIEK, J. AND SCHLOOT, W. (1994) Isolation and mapping of a cosmid clone containing the human NAT2 gene. Biochemical and Biophysical Research Communications, 199, 52-55.
14. FUJIWARA, Y., OHATA, H., KUROKI, T., KOYAMA, K., TSUCHIYA, E., MONDEN, M. AND NAKAMURA, Y. (1995) Isolation of a candidate tumour suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain on the PDGF receptor beta gene. Oncogene, 10, 891-895.
15. GOVIER, W. C. (1965) Reticuloendothelial cells as the site of sulfanilamide acetylation in the rabbit. Journal of Pharmacology and Experimental Therapeutics, 150, 305-308.
16. GRANT, D. M. (1993 Molecular genetics of N-acetyltransferases. Pharmacogenetics, 3, 45-50.
17. HAYES, R. B., BI, W., ROTHMAN, N., BROLY, F., CAPORASO, N., FENG, P., YOU, X., YIN, S., WOOSLEY, R. L. AND MEYER, U. A. (1993) N-Acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis, 14, 675-678.
18. HEIN, D. W., DOLL, M. A., RUSTAN, T. D., GRAY, K., FENG, Y., FERGUSON, R. J. AND GRANT, D. M. (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis, 14, 1633-1638.
19. HEIN, D. W., RUSTAN, T. D., FERGUSON, R. J., DOLL, M. A. AND GRAY, K. (1994) Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Archives of Toxicology, 68, 129-133.
20. HICKMAN, D., RISCH, A., BUCKLE, V., SPURR, N. K. and SIM, E. (1994) Chromosomal localization of human genes for arylamine N-acetyltransferase. Biochemical Journal, 297, 441-445.
21. HICKMAN, D., RISCH, A., CAMILLERI, J. P. AND SIM, E. (1992) Genotyping human polymorphic arylamine N-acetyltransferase identification of new slow allotypic variants. Pharmacogenetics, 2, 217-226.
22. KLOTH, M. T., GEE, R. L., MESSING, E. M. AND SWAMINATHAN, S. (1994) Expression of N-acetyltransferase (NAT) in cultured human urothoepithelial cells. Carcinogenesis, 15, 2781-2787.
23. KNOWLES, M. A., SHAW, M. E. AND PROCTOR, A. J. (1993) Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene, 8, 1357-1364.
24. MCPARTLIN, J., HALLIGAN, A., SCOTT, J. M., DARLING, M. AND WEIR, D. G. (1993) Accelerated folate breakdown in pregnancy. Lancer, 341, 148-149.
25. MCQUEEN, C. A. AND WEBER, W. W. (1980) Characterization of human lymphocyte N-acetyltransferase and its relationship to the isoniazid acetylator polymorphism. Biochemical Genetics, 18, 889-903.
26. MENDEZ, M., ERICKSON, P., SCOTT, P., DRABKIN, H. A. AND GEMMILL, R. M. (1994) Isolation of YAC clones from genomic libraries by southern blot hybridization. In YAC Libraries. A User's Guide, D. L. Nelson and B. H. Brownstein, eds (W. H. Freeman and Company, New York), pp. 57-91.
27. MINCHIN, R. F. (1995) Acetylation of para-aminobenzoylglutamate, a folate catabolite, by recombinant N-acetyltransferase and U937 cells. Biochemical Journal, 307, 1-3.
28. OHSAKO, S. AND DEGUCHI, T. (1990) Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. Journal of Biological Chemistry, 265, 4630-4634.
29. PACIFICI, G. M., BENCINI, C. AND RANE, A. (1986) Acetyltransferase in humans: development and tissue distribution. Pharmacology, 32, 283-291.
30. PRICE-EVANS, D. A., MANLY, K. A. AND MCKUSSICK, V. A. (1960) Genetic control of isoniazid metabolism in man. British Medical Journal, 2, 485-491.
31. REHN, L. (1895) Blasengeschwuelste bei Fuchsin-Arbeitern. Archive der Klinischen Chirurgie, 50, 588-600.
32. REID, T., LENGUAR, C., CREMER, T., WIEGANT, J., RAAP, A. K., PLOEG, M. V., GROITI, P. AND LIPP, M. (1992) Specific metaphase and interphase detection of the breakpoint region in 8q24 of Burkitt Lymphoma cells by triple colour fluorescence in situ hybridisation. Genes, Chromosomes and Cancer, 4, 69-74.
33. RISCH, A., WALLACE, D. M. A., BATHERS, S. AND SIM, E. (1995) Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Human Molecular Genetics, 4, 231-236.
34. SANDBERG, A. A. (1992) Chromosome changes in early bladder neoplasms. Journal of Cellular Biochemistry, 161 (Suppl.), 76-79.
35. SANDBERG, A. A. AND BERGER, C. S. (1994) Review of chromosome studies in urological tumours II. Cytogenetics and molecular genetics of bladder cancer. Journal of Urology, 151, 545-560.
36. SMITH, G., STANLEY, L. A., SIM, E., STRANGE, R. C. AND WOLF, C. R. (1995) Metabolic polymorphisms and cancer susceptibility. Cancer Surveys 25, 27-65.
37. SPURR, N. K., BLANTON, S., BOOKSTEIN, R., CLARKE, R., COTTINGHAM, R., DAIGER, S., DRAYNA, D., FABER, P., HORRIGAN, S., KAS, K., KIRCHGESSNER, C., KUMAR, S., LEACH, R. J., LUEDECKE, H.-J., NAKAMURA, Y., PEBUSQUE, M.-J., RANTA, S., SIM, E., SULLIVAN, L. S., TAKLE, L., VANCE, J., WAGNER, M., WELLS, D., WESTBROOK, C., YAREMKO, L., ZALETAYEV, D., ZUFFARDI, O. AND WOOD, S. (1995) Report of the second international workshop on human chromosome 8 mapping 1994. Cytogenics and Cell Genetics, 68, 147-164.
38. STACEY, M., BENNETT, M. S. AND HULTEN, M. (1995) FISH analysis of spontaneously arising micronuclei in the ICF syndrome. Journal of Medical Genetics, 32, 502-508.
39. STANLEY, L. A., CORONEOS, E., CUFF, R., HICKMAN, D., WARD, A. AND SIM, E. (1996) Arylamine N-acetyltransferase expression in human bladder cells: an immunochemical study. Biochemical Journal (in press).
40. STOCK, C., AMBROS, I. M., LION, T., HAAS, O. A., ZOUBEK, A. AND AMBROS, P. F. (1994) Detection of numerical and structural chromosome abnormalities in paediatric germ cell tumours by means of interphase cytogenetics. Genes, Chromosomes and Cancer, 11, 40-50.
41. TURESKY, R. J., LANG, N. P., BUTLER, M. A., TEITEL, C. AND KADLUBAR, F. F. (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1844.
42. VATSIS, K. P., WEBER, W. W., BELL, D. A., DUPRET, J.-M., PRICE-EVANS, D. A., GRANT, D. M., HEIN, D. W., LIN, H. J., MEYER, U. A., RELLING, M. V., SIM, E., SUZUKI, T. AND YAMAZOE, Y. (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics, 5, 1-17.
43. VINEIS, P., BARTSCH, H., CAPORASO, N., HARRINGTON, A. M., KADLUBAR, F. F., LANDI, M. T., MALAVELLE, C., SHIELDS, P. G., SKIPPER, P., TALASKA, G. AND TANNENBAUM, S. R. (1994) Genetically based N-acetyltransferase metabolic polymorphism and low level environmental exposure to carcinogens. Nature, 369, 154-156.
44. WARD, A., HICKMAN, D., GORDON, J. AND SIM, E. (1992) Arylamine N-acetyltransferase in human red blood cells. Biochemical Pharmacology, 44, 1099-1104.
45. WARD, A., SUMMERS, M. J. AND SIM, E. (1995) Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochemical Pharmacology, 49, 1759-1767.
46. WEBER, W. W. AND VATSIS, K. P. (1993) Individual variability in p-aminobenzoic acid N-acetylation by human N-acetyltransferase (NAT1) of peripheral blood. Pharmacogenetics, 3, 209-212.
47. WILD, D. W., FESTER, W., MICHEL, S., LORD, H. L. AND JOSEPHY, P. D. (1995) Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) expressed in Salmonella typhimurium. Carcinogenesis, 16, 643-648.
48. WOOD, S., SCHERTZER, M., DRABKIN, H., PATTERSON, D., LONGMIRE, J. L. AND DEAVEN, L. L. (1992) Characterization of a human chromosome 8 cosmid library constructed from flow-sorted chromosomes. Cytogenetics and Cell Genetics, 59, 243-247.